Kilbourn MR - Search Results

1

[3H]methoxytetrabenazine: a high specific activity ligand for estimating monoaminergic neuronal integrity.

Vander Borght TM, Sima AA, Kilbourn MR, Desmond TJ, Kuhl DE, Frey KA. Vander Borght TM, et al. Among authors: kilbourn mr. Neuroscience. 1995 Oct;68(3):955-62. doi: 10.1016/0306-4522(95)00167-h. Neuroscience. 1995. PMID: 8577387

2

The vesicular monoamine transporter is not regulated by dopaminergic drug treatments.

Vander Borght T, Kilbourn M, Desmond T, Kuhl D, Frey K. Vander Borght T, et al. Eur J Pharmacol. 1995 Dec 29;294(2-3):577-83. doi: 10.1016/0014-2999(95)00594-3. Eur J Pharmacol. 1995. PMID: 8750721

3

Striatal concentrations of vesicular monoamine transporters are identical in MPTP-sensitive (C57BL/6) and -insensitive (CD-1) mouse strains.

Kilbourn M, Frey K. Kilbourn M, et al. Eur J Pharmacol. 1996 Jun 27;307(2):227-32. doi: 10.1016/0014-2999(96)00252-x. Eur J Pharmacol. 1996. PMID: 8832225

4

In vivo imaging of the brain vesicular monoamine transporter.

Vander Borght TM, Kilbourn MR, Koeppe RA, DaSilva JN, Carey JE, Kuhl DE, Frey KA. Vander Borght TM, et al. Among authors: kilbourn mr. J Nucl Med. 1995 Dec;36(12):2252-60. J Nucl Med. 1995. PMID: 8523116 Free article.

5

In vitro and in vivo studies of benzisoquinoline ligands for the brain synaptic vesicle monoamine transporter.

Lee LC, Vander Borght T, Sherman PS, Frey KA, Kilbourn MR. Lee LC, et al. Among authors: kilbourn mr. J Med Chem. 1996 Jan 5;39(1):191-6. doi: 10.1021/jm950117b. J Med Chem. 1996. PMID: 8568807

6

Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging.

Frey KA, Koeppe RA, Kilbourn MR, Vander Borght TM, Albin RL, Gilman S, Kuhl DE. Frey KA, et al. Among authors: kilbourn mr. Ann Neurol. 1996 Dec;40(6):873-84. doi: 10.1002/ana.410400609. Ann Neurol. 1996. PMID: 9007092 Free article.

7

Differential effects of scopolamine on in vivo binding of dopamine transporter and vesicular monoamine transporter radioligands in rat brain.

Kilbourn MR, Kemmerer ES, Desmond TJ, Sherman PS, Frey KA. Kilbourn MR, et al. Exp Neurol. 2004 Aug;188(2):387-90. doi: 10.1016/j.expneurol.2004.05.001. Exp Neurol. 2004. PMID: 15246838

8

Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease.

Bohnen NI, Albin RL, Koeppe RA, Wernette KA, Kilbourn MR, Minoshima S, Frey KA. Bohnen NI, et al. Among authors: kilbourn mr. J Cereb Blood Flow Metab. 2006 Sep;26(9):1198-212. doi: 10.1038/sj.jcbfm.9600276. Epub 2006 Jan 18. J Cereb Blood Flow Metab. 2006. PMID: 16421508

9

In vivo [11C]dihydrotetrabenazine binding in rat striatum: sensitivity to dopamine concentrations.

Kilbourn MR, Butch ER, Desmond T, Sherman P, Harris PE, Frey KA. Kilbourn MR, et al. Nucl Med Biol. 2010 Jan;37(1):3-8. doi: 10.1016/j.nucmedbio.2009.08.013. Epub 2009 Oct 3. Nucl Med Biol. 2010. PMID: 20122661 Free PMC article.

10

High affinity radiopharmaceuticals based upon lansoprazole for PET imaging of aggregated tau in Alzheimer's disease and progressive supranuclear palsy: synthesis, preclinical evaluation, and lead selection.

Fawaz MV, Brooks AF, Rodnick ME, Carpenter GM, Shao X, Desmond TJ, Sherman P, Quesada CA, Hockley BG, Kilbourn MR, Albin RL, Frey KA, Scott PJ. Fawaz MV, et al. Among authors: kilbourn mr. ACS Chem Neurosci. 2014 Aug 20;5(8):718-30. doi: 10.1021/cn500103u. Epub 2014 Jun 16. ACS Chem Neurosci. 2014. PMID: 24896980 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

212 results

Search Page

Filters